No Data
No Data
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Cuts Target Price to $28
OrthoPediatrics Is Maintained at Hold by Truist Securities
Bears Are Losing Control Over OrthoPediatrics (KIDS), Here's Why It's a 'Buy' Now
Shareholders in OrthoPediatrics (NASDAQ:KIDS) Have Lost 58%, as Stock Drops 7.6% This Past Week
Does OrthoPediatrics (KIDS) Have the Potential to Rally 36.3% as Wall Street Analysts Expect?
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34
Truist Financial analyst Richard Newitter maintains $OrthoPediatrics(KIDS.US)$ with a hold rating, and sets the target price at $34.According to TipRanks data, the analyst has a success rate of 58.8%